It looks like you sent an empty JSON object. Could you clarify what you're asking for or provide more details? I'm here to help.
ByAinvest
Friday, Nov 7, 2025 9:45 am ET1min read
TNDM--
Tandem Diabetes Care surged 20.03% in intraday trading, with the company reporting third-quarter sales exceeding market expectations and updating 2025 sales guidance to $10 billion, surpassing the estimated $9.98 billion. The company, a leader in diabetes technology focused on insulin delivery systems, offers products such as the t:slim X2 and Tandem Mobi insulin pumps, available in approximately 25 countries worldwide.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet